Sort
64,565 grants matching “drug discovery”
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,917,540David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Genomics of Acute Myelogenous Leukemia
$2,917,422Timothy J Ley · Washington University · P01 · FY2017 · CA
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
$2,916,667Megan B Murray · Harvard Medical School · U19 · FY2023 · AI
Moffitt Cancer Center Support Grant
$2,913,494William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2010 · CA
Drug Repurposing Screening for Rare and Neglected Diseases
$2,908,150Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
$2,906,322Megan B Murray · Harvard Medical School · U19 · FY2021 · AI
Comprehensive Cancer Center Program at Fox Chase
$2,905,436Richard I Fisher · Research Inst Of Fox Chase Can Ctr · P30 · FY2019 · CA
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,904,544Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
$2,903,390Megan B Murray · Harvard Medical School · U19 · FY2019 · AI
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
$2,903,188Dennis William Dickson · Mayo Clinic Jacksonville · U54 · FY2020 · NS
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
$2,903,097Dai Lu · Texas A&M University Health Science Ctr · UG3 · FY2022 · NS
PENN CENTER FOR MOLECULAR DISCOVERY(RMI)
$2,899,522Scott L Diamond · University Of Pennsylvania · U54 · FY2006 · HG
Development of selective and potent protease inhibitors for corona and other pandemic viruses
$2,897,311Michael Z. Lin · Stanford University · U19 · FY2022 · AI
Targeting Cellular Senescence to Extend Healthspan
$2,897,046Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2019 · AG
Pharmacogenomics of Arrhythmia Therapy
$2,896,480Vanderbilt University · U01 · FY2005 · HL
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
$2,895,442Dennis William Dickson · Mayo Clinic Jacksonville · U54 · FY2021 · NS
Lupus Clinical Trials
$2,893,174Sarfaraz Hasni · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
OHSU Knight Cancer Institute
$2,891,535Thomas A Sellers · Oregon Health & Science University · P30 · FY2023 · CA
OHSU Knight Cancer Institute
$2,891,535Shivaani Kummar · Oregon Health & Science University · P30 · FY2025 · CA
OHSU Knight Cancer Institute
$2,891,535Brian J Druker · Oregon Health & Science University · P30 · FY2022 · CA
OHSU Knight Cancer Institute
$2,891,535Lisa M Coussens · Oregon Health & Science University · P30 · FY2024 · CA
Discovery of novel broad-spectrum coronavirus inhibitors
$2,888,994Vineet D Menachery · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Genomics of Acute Myelogenous Leukemia
$2,888,289Timothy J Ley · Washington University · P01 · FY2016 · CA
Alzheimer's Disease Neuroimaging Initiative
$2,883,054Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2022 · AG
Autonomic Pharmacodynamic Pharmacogenomics
$2,882,325University Of California San Diego · U01 · FY2001 · HL